AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

ARMOUR Residential REIT, Inc.

$15.8 -$2.29 (-12.66%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$15.84
Day Range
$15.74$16.01
Year Range
$13.98$19.31
Market Cap
1.84B
AVG Volume
3.58M
Trailing/Forward PE
4.24/5.39
PEG ratio
15.08
Dividend Yield
18.23%
Next Earnings Date
2026-10-28
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q21.01B
26 Q1993M
25 Q41.31B
25 Q3733.8M
25 Q2751.82M
25 Q1593.48M
24 Q4239.9M
24 Q31.01B
24 Q2292.15M
24 Q1244.83M
Net Income (USD) · TTM
-200M0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2430.93M
26 Q1240.5M
25 Q4322.69M
25 Q364.54M
25 Q2-28.84M
25 Q1-1.58M
24 Q4-14.39M
24 Q3131.69M
24 Q2-113.36M
24 Q1-22.05M
Operating Income (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.07B
26 Q1841.51M
25 Q4964.77M
25 Q3660.35M
25 Q2520.53M
25 Q1522.96M
24 Q4509.75M
24 Q3656.37M
24 Q2436.14M
24 Q1533.58M
EBITDA (USD) · TTM
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2993.97M
26 Q1764.28M
25 Q4967.23M
25 Q3660.35M
25 Q2520.53M
25 Q1522.96M
24 Q4509.75M
24 Q3656.37M
24 Q2436.14M
24 Q1533.57M
Cash Flows (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2319.49M
26 Q1134.28M
25 Q4124.2M
25 Q3179.08M
25 Q2264.01M
25 Q1266.13M
24 Q4261.46M
24 Q3231.36M
24 Q2211.41M
24 Q1175.41M
EPS (USD) · TTM
-4-202424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q23.72
26 Q11.92
25 Q42.73
25 Q3-0.08
25 Q2-0.36
25 Q1-0.47
24 Q4-0.55
24 Q32.36
24 Q2-2.77
24 Q1-0.72
Expenses (USD) · TTM
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q212.54M
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
Shares Outstanding (USD) · TTM
-10M010M20M30MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARR Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q29.46M
26 Q119.74M
25 Q417.82M
25 Q317.73M
25 Q27.62M
25 Q1-2.65M
24 Q4-1.9M
24 Q31.46M
24 Q21.4M
24 Q13.41M
Dividends (USD)
00.511.5Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
ARR Dividends (USD) by quarter
PeriodDividends (USD)
Sep 260.24
Aug 260.24
Jul 260.24
Jun 260.24
May 260.24
Apr 260.24
Mar 260.24
Feb 260.24
Jan 260.24
Dec 250.24
Employee Count
01020302016201720182019202020212022202320242025
ARR Employee Count by quarter
PeriodEmployee Count
202520
202420
202322
202221
202123
202022
201923
201821
201719
201619
PE Ratio
0204060med 7.39Oct 21Jan 22Nov 24Oct 25Feb 26May 26Sep 26
ARR PE Ratio by quarter
PeriodPE Ratio
Sep 264.73
Sep 264.9
Aug 264.89
Aug 264.9
Aug 265.02
Aug 265
Jul 264.94
Jul 264.88
Jul 268.26
Jul 268.48
Jul 268.52
Jun 268.58
Jun 268.33
Jun 268.5
Jun 268.51
May 268.53
May 268.24
May 268.44
May 268.77
May 268.82
Apr 268.76
Apr 266.14
Apr 266.15
Apr 265.96
Mar 265.47
Mar 265.38
Mar 265.94
Mar 266.16
Feb 266.24
Feb 266.22
Feb 2629.58
Feb 2628.59
Jan 2628.12
Jan 2629.67
Jan 2630.9
Jan 2629.25
Jan 2629.24
Dec 2528.33
Dec 2528.12
Dec 2527.33
Dec 2528.41
Nov 2528.32
Nov 2526.85
Nov 2526.98
Nov 2527.2
Oct 2526.22
Oct 2526.52
Feb 257.38
Jan 257.38
Jan 257.26
Jan 257.32
Jan 257.18
Jan 257.56
Dec 247.33
Dec 247.39
Dec 247.6
Dec 247.57
Nov 247.42
Nov 247.33
Nov 247.38
Nov 247.57
Nov 247.29
Oct 247.6
Apr 2244.35
Apr 2247.52
Apr 2248.83
Apr 2250.26
Mar 2250.32
Mar 2250.08
Mar 2251.16
Mar 2249.37
Feb 2248.77
Feb 2252.05
Feb 226.39
Feb 226.51
Jan 226.57
Jan 226.6
Jan 226.95
Jan 227.2
Dec 217.01
Dec 217.03
Dec 216.8
Dec 217.19
Dec 217.01
Nov 217.12
Nov 217.36
Nov 217.49
Nov 217.77
Oct 217.52
Oct 215.48
Oct 215.51
Oct 215.62
Oct 215.61
Sep 215.55
Sep 215.54
Sep 215.59
Sep 215.59
Aug 215.61
Aug 215.39
Aug 215.43
Free Cash Flow Yield
0%10%20%30%40%med 20.02%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARR Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2615.66%
Sep 2615.13%
Aug 2615.16%
Aug 2615.14%
Aug 2614.78%
Aug 2614.83%
Jul 2615.02%
Jul 2615.21%
Jul 266.76%
Jul 266.59%
Jul 266.56%
Jun 266.51%
Jun 266.7%
Jun 266.57%
Jun 266.56%
May 266.55%
May 266.78%
May 266.61%
May 266.37%
May 266.33%
Apr 266.37%
Apr 266.27%
Apr 266.26%
Apr 266.46%
Mar 267.03%
Mar 267.15%
Mar 266.48%
Mar 266.25%
Feb 266.16%
Feb 266.19%
Feb 269.38%
Feb 269.7%
Jan 269.87%
Jan 269.35%
Jan 268.98%
Jan 269.48%
Jan 269.49%
Dec 259.79%
Dec 259.87%
Dec 2510.15%
Dec 259.77%
Nov 259.8%
Nov 2510.34%
Nov 2510.29%
Nov 2510.2%
Oct 2510.58%
Oct 2510.46%
Oct 2520.12%
Oct 2520.14%
Oct 2520.34%
Sep 2521.62%
Sep 2521.59%
Sep 2520.56%
Sep 2519.91%
Aug 2520.58%
Aug 2520.74%
Aug 2520.92%
Aug 2520.17%
Aug 2519.23%
Jul 2518.69%
Jul 2521.47%
Jul 2521%
Jul 2520.98%
Jun 2521.34%
Jun 2521.49%
Jun 2521.12%
Jun 2521.39%
May 2521.83%
May 2522.14%
May 2521.05%
May 2521%
May 2521.81%
Apr 2522.13%
Apr 2535.05%
Apr 2535.58%
Apr 2533.26%
Mar 2529.4%
Mar 2527.05%
Mar 2526.66%
Mar 2526.37%
Feb 2526.31%
Feb 2526.54%
Feb 2526.14%
Feb 2523.82%
Jan 2523.8%
Jan 2524.2%
Jan 2524.01%
Jan 2524.45%
Jan 2523.25%
Dec 2423.97%
Dec 2423.76%
Dec 2423.11%
Dec 2423.2%
Nov 2423.68%
Nov 2423.97%
Nov 2423.82%
Nov 2423.2%
Nov 2424.1%
Oct 2423.1%
Oct 2421.29%
Price to Sales
012345med 2.06Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARR Price to Sales by quarter
PeriodPrice to Sales
Sep 262.02
Sep 262.09
Aug 262.09
Aug 262.09
Aug 262.14
Aug 262.13
Jul 262.11
Jul 262.08
Jul 262
Jul 262.05
Jul 262.06
Jun 262.08
Jun 262.02
Jun 262.06
Jun 262.06
May 262.07
May 262
May 262.04
May 262.12
May 262.14
Apr 262.12
Apr 261.52
Apr 261.52
Apr 261.47
Mar 261.35
Mar 261.33
Mar 261.47
Mar 261.52
Feb 261.54
Feb 261.54
Feb 262.6
Feb 262.51
Jan 262.47
Jan 262.61
Jan 262.72
Jan 262.57
Jan 262.57
Dec 252.49
Dec 252.47
Dec 252.4
Dec 252.5
Nov 252.49
Nov 252.36
Nov 252.37
Nov 252.39
Oct 252.31
Oct 252.33
Oct 251.75
Oct 251.74
Oct 251.73
Sep 251.62
Sep 251.63
Sep 251.71
Sep 251.76
Aug 251.71
Aug 251.69
Aug 251.68
Aug 251.74
Aug 251.83
Jul 251.88
Jul 252.09
Jul 252.14
Jul 252.14
Jun 252.1
Jun 252.09
Jun 252.12
Jun 252.1
May 252.05
May 252.03
May 252.13
May 252.14
May 252.06
Apr 252.03
Apr 253.11
Apr 253.06
Apr 253.28
Mar 253.71
Mar 254.03
Mar 254.09
Mar 254.13
Feb 254.14
Feb 254.11
Feb 254.17
Feb 250.96
Jan 250.96
Jan 250.94
Jan 250.95
Jan 250.93
Jan 250.98
Dec 240.95
Dec 240.96
Dec 240.99
Dec 240.98
Nov 240.96
Nov 240.95
Nov 240.96
Nov 240.98
Nov 240.95
Oct 240.99
Oct 243.4
EV/EBITDA
0102030med 2.33Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARR EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2621.53
Sep 2621.6
Aug 2621.6
Aug 2621.6
Aug 2621.65
Aug 2621.64
Jul 2621.61
Jul 2621.59
Jul 2626.67
Jul 2626.74
Jul 2626.75
Jun 2626.77
Jun 2626.69
Jun 2626.75
Jun 2626.75
May 2626.75
May 2626.66
May 2626.73
May 2626.83
May 2626.85
Apr 2626.83
Apr 2620.3
Apr 2620.3
Apr 2620.24
Mar 2620.08
Mar 2620.05
Mar 2620.23
Mar 2620.31
Feb 2620.33
Feb 2620.33
Feb 262.82
Feb 262.73
Jan 262.68
Jan 262.83
Jan 262.95
Jan 262.79
Jan 262.79
Dec 252.7
Dec 252.68
Dec 252.6
Dec 252.71
Nov 252.7
Nov 252.56
Nov 252.57
Nov 252.59
Oct 252.5
Oct 252.53
Oct 252.25
Oct 252.25
Oct 252.22
Sep 252.07
Sep 252.08
Sep 252.2
Sep 252.28
Aug 252.19
Aug 252.17
Aug 252.15
Aug 252.24
Aug 252.37
Jul 252.44
Jul 252.28
Jul 252.33
Jul 252.33
Jun 252.29
Jun 252.27
Jun 252.32
Jun 252.29
May 252.24
May 252.2
May 252.32
May 252.33
May 252.24
Apr 252.21
Apr 251.33
Apr 251.31
Apr 251.41
Mar 251.61
Mar 251.76
Mar 251.79
Mar 251.81
Feb 251.82
Feb 251.8
Feb 251.83
Feb 251.38
Jan 251.38
Jan 251.36
Jan 251.37
Jan 251.34
Jan 251.42
Dec 241.37
Dec 241.39
Dec 241.43
Dec 241.42
Nov 241.39
Nov 241.37
Nov 241.38
Nov 241.42
Nov 241.37
Oct 241.43
Oct 241.99
Price/Operating Cashflow
05101520med 5Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARR Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 266.39
Sep 266.61
Aug 266.6
Aug 266.6
Aug 266.77
Aug 266.74
Jul 266.66
Jul 266.58
Jul 2614.79
Jul 2615.18
Jul 2615.26
Jun 2615.37
Jun 2614.93
Jun 2615.23
Jun 2615.24
May 2615.27
May 2614.76
May 2615.12
May 2615.7
May 2615.79
Apr 2615.69
Apr 2615.94
Apr 2615.97
Apr 2615.49
Mar 2614.22
Mar 2613.99
Mar 2615.44
Mar 2616
Feb 2616.22
Feb 2616.17
Feb 2610.66
Feb 2610.3
Jan 2610.14
Jan 2610.69
Jan 2611.14
Jan 2610.54
Jan 2610.54
Dec 2510.21
Dec 2510.14
Dec 259.85
Dec 2510.24
Nov 2510.21
Nov 259.68
Nov 259.72
Nov 259.8
Oct 259.45
Oct 259.56
Oct 254.97
Oct 254.96
Oct 254.92
Sep 254.62
Sep 254.63
Sep 254.86
Sep 255.02
Aug 254.86
Aug 254.82
Aug 254.78
Aug 254.96
Aug 255.2
Jul 255.35
Jul 254.66
Jul 254.76
Jul 254.77
Jun 254.69
Jun 254.65
Jun 254.73
Jun 254.68
May 254.58
May 254.52
May 254.75
May 254.76
May 254.58
Apr 254.52
Apr 252.85
Apr 252.81
Apr 253.01
Mar 253.4
Mar 253.7
Mar 253.75
Mar 253.79
Feb 253.8
Feb 253.77
Feb 253.83
Feb 254.2
Jan 254.2
Jan 254.13
Jan 254.17
Jan 254.09
Jan 254.3
Dec 244.17
Dec 244.21
Dec 244.33
Dec 244.31
Nov 244.22
Nov 244.17
Nov 244.2
Nov 244.31
Nov 244.15
Oct 244.33
Oct 244.7
Price to Book
0.50.60.70.80.91med 0.79Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARR Price to Book by quarter
PeriodPrice to Book
Sep 260.79
Sep 260.82
Aug 260.82
Aug 260.82
Aug 260.84
Aug 260.84
Jul 260.82
Jul 260.81
Jul 260.85
Jul 260.87
Jul 260.88
Jun 260.88
Jun 260.86
Jun 260.87
Jun 260.88
May 260.88
May 260.85
May 260.87
May 260.9
May 260.91
Apr 260.9
Apr 260.88
Apr 260.88
Apr 260.85
Mar 260.78
Mar 260.77
Mar 260.85
Mar 260.88
Feb 260.89
Feb 260.89
Feb 260.9
Feb 260.87
Jan 260.85
Jan 260.9
Jan 260.94
Jan 260.89
Jan 260.89
Dec 250.86
Dec 250.85
Dec 250.83
Dec 250.86
Nov 250.86
Nov 250.81
Nov 250.82
Nov 250.82
Oct 250.79
Oct 250.8
Oct 250.79
Oct 250.79
Oct 250.78
Sep 250.74
Sep 250.74
Sep 250.77
Sep 250.8
Aug 250.77
Aug 250.77
Aug 250.76
Aug 250.79
Aug 250.83
Jul 250.85
Jul 250.73
Jul 250.74
Jul 250.74
Jun 250.73
Jun 250.73
Jun 250.74
Jun 250.73
May 250.72
May 250.71
May 250.74
May 250.74
May 250.72
Apr 250.71
Apr 250.55
Apr 250.54
Apr 250.58
Mar 250.65
Mar 250.71
Mar 250.72
Mar 250.73
Feb 250.73
Feb 250.72
Feb 250.73
Feb 250.74
Jan 250.74
Jan 250.73
Jan 250.73
Jan 250.72
Jan 250.76
Dec 240.73
Dec 240.74
Dec 240.76
Dec 240.76
Nov 240.74
Nov 240.73
Nov 240.74
Nov 240.76
Nov 240.73
Oct 240.76
Oct 240.86
ARMOUR Residential REIT, Inc.
ARR
Stockpicker

Video analysis: ARR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARR

Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer

gurufocus.com · 13 Sep 2026

Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer

Johnson and Johnson's RYBREVANTÂ (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positi

6 Ultra-High-Yield Names Where Coverage Is Cracking

247wallst.com · 12 Sep 2026

6 Ultra-High-Yield Names Where Coverage Is Cracking

A 29% yield sounds like a retirement dream until you look at what the coverage math actually says. Six popular high-yield names are flashing warning signs that patient investors can no longer afford to ignore.

A $500,000 Roth Portfolio Loaded With High-Yield Dividend Stocks Pays $40,000 a Year and the IRS Gets None of It

247wallst.com · 11 Sep 2026

A $500,000 Roth Portfolio Loaded With High-Yield Dividend Stocks Pays $40,000 a Year and the IRS Gets None of It

Mortgage REITs like ORC, ARR, and AGNC throw off some of the fattest yields on the market, but where you hold them determines whether the IRS quietly pockets a quarter of every distribution before it ever reaches you.

The Hidden Problem With These High-Yield Mortgage REIT Distributions

247wallst.com · 11 Sep 2026

The Hidden Problem With These High-Yield Mortgage REIT Distributions

Some of the highest-yielding mortgage REITs on the market are quietly handing investors back their own money while calling it income.

SpaceX Closes $1.11 Billion-a-Month Compute Deal as CFO Doubles Down on $100 Billion ARR Target

benzinga.com · 11 Sep 2026

SpaceX Closes $1.11 Billion-a-Month Compute Deal as CFO Doubles Down on $100 Billion ARR Target

Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) Chief Financial Officer Bret Johnsen says the company has closed another compute agreement that would help the Elon Musk-led space giant reach its intended $100 billion ARR target by year-end.

Is Adobe Inc (ADBE) Undervalued After Q3 Earnings Beat? EPS at $4.62, Revenue at $6.76 Billion -- GF Score: 86/100

gurufocus.com · 10 Sep 2026

Is Adobe Inc (ADBE) Undervalued After Q3 Earnings Beat? EPS at $4.62, Revenue at $6.76 Billion -- GF Score: 86/100

Adobe Inc (ADBE) released its 8-K filing on September 10, 2026, detailing impressive financial results for the third quarter of fiscal year 2026. The company's

The Dividend Trap: These Mortgage REITs Paid Investors While Destroying Principal

247wallst.com · 10 Sep 2026

The Dividend Trap: These Mortgage REITs Paid Investors While Destroying Principal

Mortgage REITs are flashing double-digit yields right now, but for some of the biggest names in the sector, those payouts have been quietly funded by eroding the very principal they promised to protect.

American Rare Earths Appoints Dr. Sanja Miskovic as Chief Technical Advisor

globenewswire.com · 10 Sep 2026

American Rare Earths Appoints Dr. Sanja Miskovic as Chief Technical Advisor

Appointment strengthens feasibility study execution and advances ARR's pathway to producing separated rare earth oxides in Wyoming Appointment strengthens feasibility study execution and advances ARR's pathway to producing separated rare earth oxides in Wyoming

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.